Abstract:Objective: Hereditary thrombocytopenias characterized by mutations in the gene for non-muscle myosin heavy chain IIA (NMMHC-IIA) are known as MYH9-related hereditary macrothrombocytopenia, and include the May-Hegglin anomaly, Sebastian platelet syndrome, Fechtner syndrome, and Epstein syndrome. Despite the presence of thrombocytopenia, these patients often have only mild or non-bleeding phenotypes. A major risk for these patients can be inappropriate treatment with long-term corticosteroids or splenectomy for misdiagnosed chronic autoimmune thrombocytopenia, as well as inadequate peri- and postoperative management. Methods: Using the case of a 44-yr-old male with Fechtner syndrome (macrothrombocytopenia, leukocyte inclusions, sensorineural deafness, glomerulonephritis) who underwent neurosurgery for an intracerebral arteriovenous malformation, we describe current methods to diagnose hereditary MYH9-related macrothombocytopenia by analysis of the blood smear, immunofluorescence staining of the NMMHC-IIA in leucocytes, and by MYH9-gene sequencing. Results: Clusters of NMMHC-IIA in granulocytes and a R1165C mutation in the MYH9-gene in two macrothrombocytopenic family members confirmed the diagnosis of a MYH9-related disease. The patient had no bleeding diathesis by history or physical examination. Thus no perioperative prohemostatic pharmacologic therapies or transfusions were given, with only minimal bleeding observed. Postoperative antithrombotic thromboprophylaxis was not given because of anticipated enhanced risk for bleeding. However, the patient developed symptomatic pulmonary embolism on postoperative day 6, which was successfully managed with 8 months of anticoagulation. Conclusion: MYH9-related hereditary macrothrombocytopenia does not necessarily protect against postoperative venous thromboembolism, and affected patients who do not evince bleeding diathesis should be considered for routine postoperative pharmacologic thromboprophylaxis.

[Hereditary macrothrombocytopenia and hearing loss]

[Hereditary sensorineural hearing impairment and macrothrombocytopenia: a rare MYH9 gene mutation]

Hereditary thrombocytopenia with familial novel mutation in MYH9 gene: A familial case report

Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia

[Hereditary thrombocytopenia associated with a mutation in the MYH-9 gene. Report of one case]

Hereditary nephritis with macrothrombocytopenia: phenotypic variety and the genotypic defect

MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches

Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome)

Maternally inherited nonsyndromic hearing loss is associated with the T7511C mutation in the mitochondrial tRNASerUCN gene in a Japanese family.

[Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 years]

[Case of an hemodialysis patient with MYH9 disorders]

Maternally Inherited Aminoglycoside-Induced and Nonsyndromic Hearing Loss is Associated with the 12S Rrna C1494T Mutation in Three Han Chinese Pedigrees.

Genotype-phenotype correlation in MYH9-related thrombocytopenia

Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes)

Maternally inherited hearing loss is associated with the novel mitochondrial tRNASer(UCN) 7505T>C mutation in a Han Chinese family

Extremely Low Penetrance of Deafness Associated with the Mitochondrial 12S Rrna T1095C Mutation in Three Chinese Families.

MYH9-related disease with a normal platelet count

A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia

Homoplasmy of the G7444A Mtdna and Heterozygosity of the GJB2 C.35delg Mutations in a Family with Hearing Loss

MYH9-related disorders display heterogeneous kidney involvement and outcome

Hereditary thrombocytopenia with platelet sialic acid deficiency and mutations in the GNE genes